Cut stroke in half: Polypill for primary prevention in stroke

Michael Brainin, Valery Feigin, Sheila Martins, Karl Matz, Jayanta Roy, Peter Sandercock, Yvonne Teuschl, Jaakko Tuomilehto, Anita Wiseman

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Übersichtsartikel

25 Zitate (Scopus)


This review summarizes the potential for polypill therapies for stroke prevention. While a number of studies applying different approaches regarding polypill have been performed, none of them has had a focus on stroke as the main outcome. A combination pill containing drugs such as statins, diuretics, and other antihypertensives is currently available in various formats. Estimates focusing mostly on primary prevention show that using such a combination drug a reduction in the 5-year stroke incidence by 50% can be achieved - especially in low- and middle-income countries with a high prevalence of risk factors even among people at young ages. A combination of a large supporting population-wide program with a registry-based quality control is the most likely perspective and can be achieved within a reasonable time frame and potentially have significant influence in young stroke populations.

Seiten (von - bis)633-647
FachzeitschriftInternational Journal of Stroke
PublikationsstatusVeröffentlicht - 01 Aug. 2018


Untersuchen Sie die Forschungsthemen von „Cut stroke in half: Polypill for primary prevention in stroke“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren